Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,214 total articles
Castellum, Inc., a cybersecurity and electronic warfare company focused on U.S. federal government clients, will release its Q2 2026 financial results on August 6, 2026, after market close and hold a conference call on August 7, 2026. The company specializes in cybersecurity, software services, AI/machine learning, 5G technologies, and national sec…
Abercrombie & Fitch Co. will release its second quarter 2026 financial results on August 26, 2026, followed by a conference call and webcast for investors and interested parties. The company operates a global omnichannel apparel business targeting kids through millennials with brands including Abercrombie and Hollister.
Swarmer, Inc, a Nasdaq-listed defense technology company specializing in autonomous swarm software, announced the date and details for its Q2 2026 earnings release and conference call scheduled for August 13, 2026. The company highlighted its ongoing role in autonomous drone operations, noting its software has supported over 100,000 combat missions…
Oxford Square Capital Corp. announced its net asset value, financial results for Q2 2026, and declared common stock distributions for October through December 2026. The company reported a slight decline in NAV to $1.29 per share from $1.32, net investment income of approximately $5.1 million, and total investment income of $9.4 million for the quar…
Picard Medical, Inc., through its subsidiary SynCardia Systems, presented for the first time the integrated architecture of its Emperor Total Artificial Heart (Emperor TAH) at the IEEE EMBC 2026 conference. This next-generation system combines the proven SynCardia Total Artificial Heart ventricles with a new patent-pending Emperor Drive System (EDS…
Mobilicom Limited, a provider of cybersecurity and robust solutions for drones and robotics, announced that it will release its financial and operational results for the six months ended June 30, 2026, on August 13, 2026, after Nasdaq market close. A conference call and webcast will follow for management to discuss results and recent developments. …
ATIF Holdings Limited (Nasdaq: AUC) announced an agreement to acquire GoldCoin Labs Limited, a company developing tokenized digital gold assets. The all-share transaction valued at $20 million aims to advance ATIF's strategy in blockchain-based gold investment products, complementing their existing digital asset services and positioning them for gr…
Space-Eyes, a U.S.-based geospatial intelligence and AI-powered counter-unmanned aerial system provider, has agreed to merge with McKinley Acquisition Corp. in a business combination expected to close in Q4 2026. The combined company will trade on Nasdaq under the ticker CUAS with a pro forma equity valuation of $638 million. The transaction includ…
Star Group, L.P., a leading home energy distributor in the Northeast and Mid-Atlantic U.S., announced it will release its fiscal 2026 third quarter results after market close on August 5, 2026, with a webcast and conference call scheduled for August 6. The company serves residential and commercial customers with home heating products, propane, and …
Hudbay Minerals Inc. announced a correction to the record date and payment date for its upcoming quarterly cash dividend of C$0.01 per share to be paid in September 2026. The corrected record date is September 8, 2026, and the payment date is September 25, 2026. Other dividend terms remain unchanged. The company emphasized its continued focus on su…
Wearable Devices Ltd. has entered into a private placement agreement with a single institutional investor to raise approximately $3.3 million through the issuance of 1,000,000 shares and accompanying warrants exercisable over five years. The capital raised will fund commercialization of Mudra products, development of next-generation devices, AI6 La…
Elutia Inc., a biotechnology company specializing in drug-eluting biomatrix technologies, announced it will release its second quarter 2026 financial results after market close on August 13, 2026. The company will host a conference call and webcast to discuss the earnings. Elutia focuses on improving compatibility between medical devices and patien…
Acorn Energy, Inc., through its subsidiary OmniMetrix, will report its Q2 2026 earnings and hold a conference call on August 6th. The company specializes in wireless remote monitoring and control solutions for critical infrastructure such as generators, gas pipelines, cell towers, and data centers, serving commercial, governmental, and residential …
J-Star Holding Co., Ltd. announced that it has regained compliance with Nasdaq's minimum bid price listing requirement after maintaining a stock price above $1.00 for 10 consecutive trading days. The company remains listed on The Nasdaq Capital Market under ticker YMAT. Following a Nasdaq Hearings Panel review, J-Star presented its strategic roadma…
IES Holdings, Inc. reported robust financial results for the third quarter of fiscal 2026, including a 40% increase in revenue to $1.24 billion and a 60% increase in operating income to $178.5 million compared to the prior year quarter. Net income nearly doubled with a 98% increase to $153 million. The company also announced a two-for-one stock spl…
Dragonfly Energy Holdings Corp. announced the acquisition of substantially all operating assets of Dakota Lithium, expanding its presence in marine, outdoor recreation, powersports, and other specialty battery markets. With Dakota Lithium generating approximately $12 million in net revenue in 2025 despite product availability constraints, Dragonfly…
Medicus Pharma announced that the UAE Department of Health has granted Investigational New Drug authorization for the PRECISION-E2 Phase 2a study evaluating Teverelix® in women with moderate-to-severe endometriosis. This study is a pioneering genomics-guided precision medicine trial aiming to optimize treatment by integrating genetic, pharmacologic…
YXT.com Group Holding Limited has successfully regained compliance with Nasdaq's minimum bid price requirement by increasing its ADS ratio from 1:3 to 1:30, resulting in the ADS closing price meeting or exceeding $1.00 for 10 consecutive business days. This reinstates the company’s standing on the Nasdaq exchange after earlier notices of non-compli…
Digital Currency X Technology Inc. announced that CEO Melissa Chen purchased 41,000 Class A ordinary shares on the open market at an average price of $1.25 per share, underscoring her confidence in the company's long-term strategic plans focused on digital asset treasury management and custody solutions for institutional investors.
TransAlta Corporation announced its Q2 2026 financial results showcasing strong operational performance and positive net earnings compared to the prior year loss. The company highlighted progress on strategic projects including a major acquisition in Colorado and energy transition efforts. Despite challenging Alberta market conditions, TransAlta ac…
Ocugen, Inc., a US biotech company specializing in gene therapies for blindness, announced upcoming presentations at two major August 2026 investor conferences. The company will discuss its modifier gene therapy platform designed to address multiple gene networks involved in blindness-related diseases like retinitis pigmentosa and geographic atroph…
GCL Global Holdings Ltd. announced its fiscal year 2026 results, showcasing a 68.2% increase in revenues driven by the expansion of its gaming distribution and publishing operations. Despite strong revenue growth to $238.9 million, the company reported a net loss of $26.2 million due to substantial one-time expenses related to acquisitions and plat…
Tenax Therapeutics announced its second quarter financial results for 2026 and updated investors on its clinical progress, including the expectation of topline data from its Phase 3 LEVEL clinical trial for PH-HFpEF in August 2026. The company reported increased R&D expenses due to ongoing Phase 3 trials and has $118 million in cash, extending its …
INmune Bio Inc., a late-stage biotechnology firm, announced receipt of about $4.6 million in non-dilutive research and development rebates from Australia and the UK. These incentives bolster the company’s cash position, exceed its quarterly operating cash used, and support ongoing development and regulatory filing efforts for its lead drug candidat…
Werewolf Therapeutics announced its second quarter 2026 financial results highlighted by a $21 million asset sale to Jazz Pharmaceuticals, repayment of debt, and a net income of $3.7 million compared to a loss last year. The company maintains a cash runway into Q2 2027 and is exploring strategic alternatives with Piper Sandler while progressing its…
